Dusp6 inhibits epithelial-mesenchymal transition in endometrial adenocarcinoma via ERK signaling pathway
Endometrial adenocarcinoma (EAC) is one of the most commonly diagnosed gynaecological malignancies among female population of the developed countries. DUSP6 is a negative regulator of ERK signaling, which is a molecular switch involved in MAPK signaling during the progress of malignancies. DUSP6 was...
Main Authors: | Fan Ming-Jun, Liang Shu-Mei, He Peng-Juan, Zhao Xing-Bo, Li Ming-Jiang, Geng Feng |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2019-09-01
|
Series: | Radiology and Oncology |
Subjects: | |
Online Access: | https://doi.org/10.2478/raon-2019-0034 |
Similar Items
-
A positive feedback loop of ARF6 activates ERK1/2 signaling pathway via DUSP6 silencing to promote pancreatic cancer progression
by: Xiao Bingkai, et al.
Published: (2022-08-01) -
Dual-specificity phosphatase (DUSP6) in human glioblastoma: epithelial-to-mesenchymal transition (EMT) involvement
by: Candida Zuchegna, et al.
Published: (2020-08-01) -
DUSP2 Deletion Inhibits Macrophage Migration by Inhibiting ERK Activation in Zebrafish
by: Yu-Jiao Li, et al.
Published: (2023-06-01) -
Upregulation of DUSP6 impairs infectious bronchitis virus replication by negatively regulating ERK pathway and promoting apoptosis
by: Huan Wang, et al.
Published: (2021-01-01) -
Periostin mediates epithelial-mesenchymal transition through the MAPK/ERK pathway in hepatoblastoma
by: Lu Chen, et al.
Published: (2019-03-01)